Robert Ford is Chairman of the Board and Chief Executive Officer of Abbott Laboratories (ABT). The company reported total compensation of $24,198,660 for fiscal year 2025.
| Salary | $1,500,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $8,787,378 |
| Option awards | $8,788,430 |
| Non-equity incentive plan | $1,968,750 |
| Pension and non-qualified deferred compensation | $2,194,304 |
| All other compensation | $959,798 |
| Total | $24,198,660 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Abbott Laboratories filed March 13, 2026, accession 0001308179-26-000064.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chairman of the Board and Chief Executive Officer | $1,500,000 | $0 | $8,787,378 | $8,788,430 | $1,968,750 | $2,194,304 | $959,798 | $24,198,660 |
| FY2024 | Chairman of the Board and Chief Executive Officer | $1,500,000 | $0 | $8,226,593 | $8,227,441 | $2,861,250 | $1,342,793 | $618,998 | $22,777,075 |
| FY2023 | Chairman of the Board and Chief Executive Officer | $1,500,000 | $0 | $7,436,600 | $7,437,649 | $2,945,250 | $3,665,280 | $283,392 | $23,268,171 |
| FY2022 | Chairman of the Board and Chief Executive Officer | $1,500,000 | $0 | $8,699,609 | $8,699,985 | $2,231,250 | $269,586 | $321,722 | $21,722,152 |
| FY2021 | Chairman of the Board and Chief Executive Officer | $1,482,692 | $0 | $8,689,294 | $8,689,978 | $3,168,400 | $2,755,343 | $129,179 | $24,914,886 |
| FY2020 | Chairman of the Board and Chief Executive Officer | $1,298,462 | $0 | $5,623,995 | $5,624,993 | $3,675,000 | $4,150,264 | $77,872 | $20,450,586 |
| FY2019 | Chairman of the Board and Chief Executive Officer | $1,000,000 | $0 | $3,475,992 | $3,476,054 | $1,562,500 | $2,311,499 | $71,841 | $11,897,886 |
Totals as disclosed in each year's own compensation disclosure for Abbott Laboratories.
| Peer-group chief executive median | $23,556,720 |
|---|---|
| Difference from that median | $641,941 |
| Percentile within the disclosed peer group | 67th |
| Peers with a disclosed figure | 18 |
Medians and percentiles are computed across the peer group Abbott Laboratories discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Robert Ford this page | Chairman of the Board and Chief Executive Officer | $24,198,660 |
| Philip Boudreau | Executive Vice President, Finance and Chief Financial Officer | $9,090,636 |
| Lisa Earnhardt | Executive Vice President and Group President, Medical Devices | $8,069,724 |
| Hubert Allen | Former Executive Vice President, General Counsel and Secretary | $6,995,583 |
| Christopher Scoggins | Executive Vice President, Diabetes Care | $6,601,667 |
| Daniel Salvadori | Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products | $6,534,285 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Abbott Laboratories compensation brief.
Robert Ford's compensation sits inside Abbott Laboratories's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.